Illegal Sale of E-cigarettes Persists in Lucknow Despite Ban

Feb.19.2025
Illegal Sale of E-cigarettes Persists in Lucknow Despite Ban
Despite India's ban on e-cigarette sales, shops in Lucknow openly defy the law, offering delivery services and various flavors.

According to a report by Hindustan Times on February 18, despite the ban on production, sale, import, export, transportation, and promotion of e-cigarettes in India having taken effect, the devices are still openly being sold.

 

The Indian government banned the sale of e-cigarettes on September 18, 2019, but vendors continue to sell these products through small shops and grocery stores. According to an investigation by the Hindustan Times, there are quite a few shops not only selling e-cigarettes, but also offering home delivery services, easily bypassing legal restrictions. During a field investigation in Lucknow Division in Indira from February 15th to 16th, Hindustan Times found at least four to five shops openly selling e-cigarettes, where the shop owners introduce and sell various flavors of e-cigarettes and disposable e-cigarettes ranging from 6,000 to 30,000 puffs.

 

A vendor at Janpath Market said that he can deliver e-cigarettes across the city for no extra charge. It is reported that 6,000 puffs of e-cigarettes are priced at 1,400 rupees (16 USD), while 30,000 are 2,400 rupees (28 USD). Multiple flavors are available, and discreet delivery is even possible upon request.

 

Another vendor is selling e-cigarettes with a starting capacity of 10,000 puffs for 1,600 rupees (18 USD) and is offering home delivery services. However, he stated that once sold, refunds or exchanges would not be supported.

 

In another area, a seller confirmed the supply of e-cigarettes and stated that customers can place orders over the phone, make payments using UPI, and get home delivery services. Compared to the Delhi market, e-cigarettes are harder to get supplies and a lower price in Lucknow. Currently, the main brands in Lucknow are IGET and ELFBAR.

 

Vijay Pratap Singh, Assistant Commissioner of the Food Safety and Drug Administration (FSDA) in Lucknow, stated that the FSDA will issue warnings to illegal vendors, and if they do not comply, their products will be sealed and banned for sale. However, the current regulations do not have sufficient penalties, as offenders only need to pay a fine of 200 rupees (2 dollars) per item to avoid harsher punishment. Additionally, the police have the authority to independently crackdown on these illegal activities.

 

Previously, 2Firsts had an exclusive interview with Kartik Laijawala, the CEO of Nico Orgo, which is the top nicotine enterprise in India, sharing his opinions about the trend of stricter regulations on sythetic nicotine, the ban of disposable e-cigarettes, etc. For more information, please refer to the full report: As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview. 

Illegal Sale of E-cigarettes Persists in Lucknow Despite Ban
Kartik Laijawala, the CEO of Nico Orgo | Source: 2Firsts

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives